November 2, 2017
Researchers at Mayo Clinic Center for Individualized Medicine have uncovered genetic clues to why tumors resist a specific therapy used for treating advanced prostate cancer. This discovery can guide health care providers to individualized treatments for castration-resistant prostate cancer, a deadly disease that does not respond to standard hormone therapy. Several U.S. Food and Drug […]
Tags: Advanced prostate cancer, castration-resistant prostate cancer, center for individualized medicine, Dr. Keith Stewart, Dr. Liewei Wang, Dr. Manish Kohli, individualized medicine, medical research, personalized medicine, Precision Medicine, Prostate Cancer, RNA sequencing
October 22, 2013
Understanding Prostate Cancer, One Man At A Time
By AJ Montpetit
The Prostate Cancer Medically Optimized Genome-Enhanced Therapy (PROMOTE) study uses genetic clues in castration-resistant prostate cancer (CPRC) that may identify an individualized treatment approach for men with the disease. Those with advanced prostate cancer can have tumors resistant to standard hormone treatments that lower testosterone. Our goal is to improve treatments by using genetic sequencing to uncover […]
Tags: Biopsy, cancer, castration resistent prostate cancer, castration-resistant prostate cancer, center for individualized medicine, CRPC, DNA, DNA Sequencing, genetic, Genetic Counseling, Genetic Sequencing, Genetics